TBPH Theravance Biopharma, Inc.
Fundamentals / CIK 0001583107 / USDTheravance Biopharma, Inc. reported $104.3M in revenue and net income of $53.81M for the trailing twelve months ended June 30, 2026 (down 20.9% year over year), with a -4.0% operating margin.
Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open TBPH in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.
-
Revenue TTM$104.3M -20.9% YoY
-
Operating Income TTM-$4.20M -4.0% margin
-
Net Income TTM$53.81M 51.6% net margin
-
Diluted EPS TTM$1.01 Split-adjusted
-
Free Cash Flow TTM$238.5M 228.6% FCF margin
-
Cash & ST Investments Jun 30, 2026$387.7M Total debt: $38.57M
Annual revenue and net income
10 fiscal years (2016 to 2025), reported in USD.
Financial statements and ratios
Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.
Income Statement (Annual) · Reported in USD · Newest filing period first.
| Income Statement | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $107.5M | $64.38M | $57.42M | $51.35M | $55.31M | $71.86M | $73.41M | $60.37M | $15.39M | $48.65M |
| Cost of Revenue | -- | -- | -- | -- | -- | -- | -- | -- | $6.03M | $2.89M |
| Gross Profit | -- | -- | -- | -- | -- | -- | -- | -- | $9.36M | $45.75M |
| Research & Development | $37.41M | $37.64M | $40.62M | $63.39M | $193.7M | $261.0M | $219.2M | $201.3M | $173.9M | $141.7M |
| Selling, General & Admin | $73.65M | $69.17M | $70.09M | $67.07M | $99.30M | $108.5M | $106.1M | $97.06M | $95.59M | $84.51M |
| Total Operating Expenses | $111.1M | $111.3M | $113.5M | $143.3M | $313.1M | $369.5M | $325.3M | $299.1M | $275.5M | $229.1M |
| Operating Income | -$3.60M | -$46.95M | -$56.03M | -$91.96M | -$257.8M | -$297.6M | -$251.9M | -$238.8M | -$260.1M | -$180.5M |
| EBITDA | -$2.10M | -$45.35M | -$54.13M | -$89.36M | -$254.3M | -$294.3M | -$248.6M | -$235.6M | -$256.1M | -$177.3M |
| Interest Expense | $2.46M | $2.55M | $2.35M | $6.37M | $8.55M | $8.55M | $31.86M | $10.48M | $8.55M | $1.40M |
| Income Before Tax | $129.2M | -$44.61M | -$49.27M | -$92.81M | -$265.2M | -$303.3M | -$241.7M | -$226.1M | -$271.7M | -$180.6M |
| Income Tax Expense | $23.35M | $11.80M | $5.92M | $9.0K | -$151K | -$8.52M | -$5.22M | -$10.56M | $13.69M | $10.11M |
| Net Income | $105.9M | -$56.42M | -$55.19M | $872.1M | -$199.4M | -$278.0M | -$236.5M | -$215.5M | -$285.4M | -$190.7M |
| Basic EPS | $2.10 | -$1.15 | -$1.00 | $11.85 | -$2.87 | -$4.46 | -$4.25 | -$3.99 | -$5.45 | -$4.26 |
| Diluted EPS | $2.06 | -$1.15 | -$1.00 | $11.85 | -$2.87 | -$4.46 | -$4.25 | -$3.99 | -$5.45 | -$4.26 |
| Basic Shares Outstanding | 50.3M | 48.8M | 55.3M | 73.6M | 69.5M | 62.3M | 55.6M | 55.1M | 53.7M | 44.7M |
| Diluted Shares Outstanding | 51.5M | 48.8M | 55.3M | 73.6M | 69.5M | 62.3M | 55.6M | 54.0M | 52.4M | 44.7M |
Income Statement (Quarterly) · Reported in USD · Newest filing period first.
| Income Statement | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $20.73M | $17.70M | $45.89M | $19.99M | $26.20M | $15.39M | $18.75M | $16.87M |
| Research & Development | $4.71M | $5.83M | $7.36M | $8.11M | $10.49M | $11.45M | $9.45M | $9.27M |
| Selling, General & Admin | $14.18M | $17.72M | $18.52M | $18.33M | $18.43M | $18.37M | $18.50M | $16.88M |
| Total Operating Expenses | $29.01M | $27.18M | $25.88M | $26.45M | $28.92M | $29.82M | $27.95M | $27.70M |
| Operating Income | -$8.28M | -$9.48M | $20.01M | -$6.46M | -$2.73M | -$14.43M | -$9.20M | -$10.84M |
| Interest Expense | -- | -- | $582K | $573K | $663K | $643K | $643K | $630K |
| Income Before Tax | -$4.79M | -$6.47M | $73.07M | -$2.89M | $73.21M | -$14.14M | -$8.94M | -$10.05M |
| Income Tax Expense | $1.11M | -$1.54M | $12.04M | -$6.50M | $18.37M | -$559K | $6.59M | $2.65M |
| Net Income | -$5.90M | -$4.93M | $61.02M | $3.62M | $54.84M | -$13.58M | -$15.53M | -$12.70M |
| Basic EPS | -$0.11 | -$0.10 | $1.20 | $0.07 | $1.09 | -$0.27 | -$0.31 | -$0.26 |
| Diluted EPS | -$0.11 | -$0.10 | $1.15 | $0.07 | $1.08 | -$0.27 | -$0.31 | -$0.26 |
| Basic Shares Outstanding | 51.7M | 51.3M | -- | 50.5M | 50.2M | 49.7M | -- | 49.0M |
| Diluted Shares Outstanding | 51.7M | 51.3M | -- | 51.9M | 50.7M | 49.7M | -- | 49.0M |
Balance Sheet (Annual) · Reported in USD · Newest filing period first.
| Balance Sheet | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $167.8M | $37.80M | $39.55M | $298.2M | $89.96M | $81.47M | $58.06M | $378.0M | $88.98M | $344.7M |
| Short-Term Investments | $147.6M | $50.55M | $62.88M | $29.31M | $83.51M | $211.5M | $222.8M | $127.3M | $259.6M | $156.4M |
| Cash & Short-Term Investments | $315.4M | $88.35M | $102.4M | $327.5M | $173.5M | $292.9M | $280.8M | $505.3M | $348.6M | $501.1M |
| Accounts Receivable, Net | -- | -- | -- | -- | -- | -- | -- | $620K | $2.25M | $646K |
| Inventory | -- | -- | -- | -- | -- | -- | -- | $0 | $16.83M | $12.22M |
| Total Current Assets | $418.5M | $161.1M | $133.5M | $353.5M | $249.9M | $393.3M | $338.5M | $532.8M | $378.7M | $528.5M |
| Property, Plant & Equipment, Net | $5.89M | $7.42M | $9.07M | $11.88M | $13.66M | $16.42M | $12.64M | $13.18M | $10.16M | $8.46M |
| Long-Term Investments | $11.13M | -- | -- | -- | -- | -- | $4.99M | $11.87M | $41.59M | $91.56M |
| Other Non-Current Assets | $24.88M | $12.29M | $8.07M | $6.90M | $3.23M | $2.45M | $1.59M | $1.53M | $1.88M | $1.89M |
| Total Non-Current Assets | $67.11M | $193.1M | $248.5M | $253.9M | $124.9M | $75.72M | $70.34M | $27.41M | $62.65M | $110.8M |
| Total Assets | $485.6M | $354.2M | $382.0M | $607.4M | $374.8M | $469.1M | $408.8M | $560.2M | $441.4M | $639.3M |
| Accounts Payable | $2.57M | $2.24M | $1.52M | $1.55M | $3.10M | $6.78M | $4.76M | $9.03M | $5.92M | $1.73M |
| Deferred Revenue (Current) | -- | -- | -- | $24K | $98K | $11.52M | $31.57M | $43.40M | $125K | $152K |
| Total Current Liabilities | $38.30M | $32.09M | $24.77M | $28.71M | $58.59M | $123.6M | $111.7M | $98.55M | $62.55M | $49.27M |
| Long-Term Debt | -- | -- | $0 | -- | $616.3M | $619.2M | $455.0M | $454.4M | $223.7M | -- |
| Deferred Revenue (Non-Current) | -- | -- | -- | $192K | $310K | $348K | $6.76M | $26.18M | $1.44M | -- |
| Other Non-Current Liabilities | $313K | $1.89M | $5.92M | $1.66M | $2.18M | $1.83M | $21.29M | $24.76M | $34.82M | $13.11M |
| Total Non-Current Liabilities | $150.5M | $146.5M | $144.2M | $136.9M | $654.8M | $649.2M | $521.0M | $513.3M | $263.7M | $239.8M |
| Total Liabilities | $188.8M | $178.6M | $169.0M | $165.6M | $713.4M | $772.8M | $632.7M | $611.8M | $326.2M | $289.0M |
| Total Debt (incl. Leases) | $42.70M | $49.82M | $49.16M | $52.16M | $669.5M | $676.3M | $510.5M | $454.4M | $223.7M | -- |
| Common Stock | $1.0K | -- | -- | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K |
| Retained Earnings | -$859.6M | -$965.5M | -$909.1M | -$853.9M | -$1.73B | -$1.53B | -$1.25B | -$1.01B | -$797.7M | -$512.2M |
| Accumulated Other Comp. Income | $61K | $7.0K | -$65K | -$15K | -- | $47K | $145K | -$166K | -$733K | -$253K |
| Total Stockholders' Equity | $296.7M | $175.5M | $213.0M | $441.8M | -$338.6M | -$303.8M | -$223.8M | -$51.59M | $115.2M | $350.2M |
| Total Equity | $296.7M | $175.5M | $213.0M | $441.8M | -$338.6M | -$303.8M | -$223.8M | -$51.59M | $115.2M | $350.2M |
Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.
| Balance Sheet | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $219.8M | $288.1M | $167.8M | $174.8M | $281.9M | $110.6M | $37.80M | $23.38M |
| Short-Term Investments | $167.9M | $106.6M | $147.6M | $154.9M | $56.88M | $20.24M | $50.55M | $67.98M |
| Cash & Short-Term Investments | $387.7M | $394.7M | $315.4M | $329.7M | $338.8M | $130.9M | $88.35M | $91.36M |
| Total Current Assets | $416.7M | $417.6M | $418.5M | $354.7M | $366.3M | $150.3M | $161.1M | $116.5M |
| Property, Plant & Equipment, Net | $5.17M | $5.54M | $5.89M | $6.26M | $6.64M | $7.03M | $7.42M | $7.79M |
| Long-Term Investments | -- | -- | $11.13M | $3.03M | -- | -- | -- | -- |
| Other Non-Current Assets | $25.18M | $25.30M | $24.88M | $25.19M | $25.77M | $13.82M | $12.29M | $7.47M |
| Total Non-Current Assets | $53.11M | $54.68M | $67.11M | $60.76M | $59.74M | $193.3M | $193.1M | $239.6M |
| Total Assets | $469.8M | $472.3M | $485.6M | $415.5M | $426.0M | $343.6M | $354.2M | $356.1M |
| Accounts Payable | $652K | $1.10M | $2.57M | $2.21M | $1.68M | $2.41M | $2.24M | $1.45M |
| Total Current Liabilities | $30.77M | $31.77M | $38.30M | $37.41M | $54.63M | $31.50M | $32.09M | $23.43M |
| Other Non-Current Liabilities | $244K | $244K | $313K | $313K | $1.55M | $1.29M | $1.89M | $4.98M |
| Total Non-Current Liabilities | $149.3M | $149.9M | $150.5M | $145.4M | $146.6M | $146.1M | $146.5M | $147.0M |
| Total Liabilities | $180.1M | $181.7M | $188.8M | $182.8M | $201.2M | $177.6M | $178.6M | $170.5M |
| Total Debt (incl. Leases) | $38.57M | $40.50M | $42.70M | $44.59M | $46.46M | $48.16M | $49.82M | $44.98M |
| Common Stock | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | -- | -- |
| Retained Earnings | -$870.5M | -$864.6M | -$859.6M | -$920.7M | -$924.3M | -$979.1M | -$965.5M | -$950.0M |
| Accumulated Other Comp. Income | -$76K | -$62K | $61K | $32K | -$10K | -- | $7.0K | $50K |
| Total Stockholders' Equity | $289.7M | $290.6M | $296.7M | $232.7M | $224.8M | $166.0M | $175.5M | $185.7M |
| Total Equity | $289.7M | $290.6M | $296.7M | $232.7M | $224.8M | $166.0M | $175.5M | $185.7M |
Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.
| Cash Flow Statement | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | $105.9M | -$56.42M | -$55.19M | $872.1M | -$199.4M | -$278.0M | -$236.5M | -$215.5M | -$285.4M | -$190.7M |
| Depreciation & Amortization | $1.50M | $1.60M | $1.90M | $2.60M | $3.50M | $3.30M | $3.30M | $3.17M | $4.03M | $3.12M |
| Stock-Based Compensation | $18.48M | $21.39M | $25.37M | $39.73M | $62.06M | $62.98M | $60.45M | $51.31M | $49.15M | $41.17M |
| Change in Receivables | -- | -- | -- | -- | -- | -- | $620K | $1.63M | -$1.61M | $1.28M |
| Change in Inventory | -- | -- | -- | -- | -- | -- | -- | -$1.63M | -$7.30M | -$3.18M |
| Change in Payables | $326K | $750K | $6.0K | -$1.61M | -$3.53M | $3.66M | -$4.27M | $3.58M | $3.80M | -$16.44M |
| Operating Cash Flow | $238.5M | -$11.54M | -$27.00M | -$187.0M | -$207.9M | -$250.4M | -$238.2M | -$112.9M | -$201.1M | -$98.99M |
| Capital Expenditure | -$42K | -$332K | -$2.49M | -$572K | -$3.41M | -$6.62M | -$3.18M | -$7.24M | -$2.41M | -$2.13M |
| Free Cash Flow | $238.5M | -$11.87M | -$29.48M | -$187.6M | -$211.3M | -$257.0M | -$241.4M | -$120.1M | -$203.5M | -$101.1M |
| Purchases of Investments | -$248.2M | -$140.7M | -$134.5M | -$103.1M | -$158.3M | -$402.0M | -$423.9M | -$183.3M | -$288.8M | -$237.6M |
| Investing Cash Flow | -$105.3M | $12.28M | -$32.70M | $1.15B | $124.5M | $10.72M | -$83.05M | $176.7M | -$56.33M | -$148.2M |
| Common Stock Issued | $20K | $99K | -- | -- | $108.2M | $139.9M | -- | -- | $0 | $253.0M |
| Share Repurchases | -- | -$445K | -$197.1M | -$128.8M | -- | -- | -- | -- | -- | -- |
| Financing Cash Flow | -$3.25M | -$2.50M | -$198.9M | -$758.8M | $91.86M | $263.1M | $1.29M | $225.2M | $1.66M | $479.2M |
| Net Change in Cash | $130.0M | -$1.75M | -$258.6M | $208.2M | $8.50M | $23.40M | -$320.0M | $289.0M | -$255.7M | $232.0M |
Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.
| Cash Flow Statement | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|---|---|---|---|
| Net Income | -$5.90M | -$4.93M | $61.02M | $3.62M | $54.84M | -$13.58M | -$15.53M | -$12.70M |
| Stock-Based Compensation | $5.99M | $4.50M | $4.48M | $4.58M | $4.54M | $4.88M | $5.83M | $4.96M |
| Change in Payables | -$448K | -$1.47M | $355K | $538K | -$733K | $166K | $788K | -$220K |
| Operating Cash Flow | -$6.96M | $73.28M | -$6.06M | -$6.51M | $208.1M | $43.04M | -$902K | -$5.20M |
| Capital Expenditure | -- | -- | -- | -- | -- | -- | -$190K | -$15K |
| Free Cash Flow | -- | -- | -- | -- | -- | -- | -$1.09M | -$5.21M |
| Purchases of Investments | -$101.9M | -$43.41M | -$64.93M | -$124.7M | -$56.57M | -$1.97M | -$37.72M | -$44.88M |
| Investing Cash Flow | -$60.40M | $52.59M | $588K | -$100.2M | -$36.26M | $30.63M | $15.69M | -$17.40M |
| Common Stock Issued | -- | -- | $0 | $0 | $0 | $20K | -- | -- |
| Share Repurchases | -- | -- | -- | -- | -- | -- | $0 | $0 |
| Financing Cash Flow | -$967K | -$5.58M | -$1.49M | -$400K | -$503K | -$854K | -$365K | -$372K |
| Net Change in Cash | -$68.33M | $120.3M | -$6.97M | -$107.2M | $171.3M | $72.82M | $14.42M | -$22.97M |
Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.
| Ratios & Growth | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | -- | -- | -- | -- | -- | -- | -- | -- | 60.8% | 94.1% |
| Operating Margin | -3.4% | -72.9% | -97.6% | -179.1% | -466.1% | -414.2% | -343.1% | -395.5% | -1690.6% | -371.0% |
| Net Profit Margin | 98.5% | -87.6% | -96.1% | 1698.5% | -360.6% | -386.9% | -322.1% | -357.0% | -1855.0% | -391.9% |
| Return on Equity (ROE) | 35.7% | -32.1% | -25.9% | 197.4% | -- | -- | -- | -- | -247.8% | -54.4% |
| Return on Assets (ROA) | 21.8% | -15.9% | -14.4% | 143.6% | -53.2% | -59.3% | -57.8% | -38.5% | -64.7% | -29.8% |
| Current Ratio | 10.93x | 5.02x | 5.39x | 12.31x | 4.26x | 3.18x | 3.03x | 5.41x | 6.05x | 10.73x |
| Quick Ratio | 8.23x | 2.75x | 4.14x | 11.40x | 2.96x | 2.37x | 2.51x | 5.41x | 5.79x | 10.48x |
| Debt to Equity | 0.14x | 0.28x | 0.23x | 0.12x | -- | -- | -- | -- | 1.94x | -- |
| Revenue Growth (YoY) | +66.9% | +12.1% | +11.8% | -7.2% | -23.0% | -2.1% | +21.6% | +292.4% | -68.4% | +15.5% |
| Gross Profit Growth (YoY) | -- | -- | -- | -- | -- | -- | -- | -- | -79.6% | +22.1% |
| Net Income Growth (YoY) | -- | -- | -106.3% | -- | -- | -- | -- | -- | -- | -- |
| EPS Growth (YoY) | -- | -- | -108.4% | -- | -- | -- | -- | -- | -- | -- |
| 5Y Revenue / Share Growth | +85.3% | -0.2% | -5.3% | +143.5% | -26.8% | -6.6% | +258.7% | +15294.7% | -93.0% | -- |
| 10Y Revenue / Share Growth | +73.1% | +258.1% | +14483.3% | -83.0% | -- | -- | -- | -- | -- | -- |
Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.
| Ratios & Growth | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|---|---|---|---|
| Operating Margin | -4.0% | 1.2% | -3.4% | -40.9% | -48.2% | -76.9% | -72.9% | -69.6% |
| Net Profit Margin | 51.6% | 104.3% | 98.5% | 36.5% | 16.9% | -89.4% | -87.6% | -78.2% |
| Return on Equity (ROE) | 18.6% | 39.4% | 35.7% | 12.6% | 5.8% | -35.1% | -32.1% | -26.6% |
| Return on Assets (ROA) | 11.5% | 24.3% | 21.8% | 7.1% | 3.1% | -17.0% | -15.9% | -13.9% |
| Current Ratio | 13.54x | 13.14x | 10.93x | 9.48x | 6.70x | 4.77x | 5.02x | 4.97x |
| Quick Ratio | 12.60x | 12.42x | 8.23x | 8.81x | 6.20x | 4.15x | 2.75x | 3.90x |
| Debt to Equity | 0.13x | 0.14x | 0.14x | 0.19x | 0.21x | 0.29x | 0.28x | 0.24x |
| Revenue Growth (YoY) | -20.9% | +15.0% | +144.7% | +18.5% | +83.7% | +6.1% | +6.8% | +7.5% |
| Net Income Growth (YoY) | -110.8% | -- | -- | -- | -- | -- | -- | -- |
| EPS Growth (YoY) | -110.1% | -- | -- | -- | -- | -- | -- | -- |
| Operating Cash Flow Growth (YoY) | -103.3% | +70.3% | -- | -- | -- | -- | -- | -- |